VeroVaccines GmbH. (7/17/17). "Press Release: VeroVaccines GmbH Founded in Halle (Saale), Germany".

	Region	Halle (Saale)
	Country	Germany
	Organisation	VeroVaccines GmbH
	Organisation 2	BMBF (Federal Ministry for Education and Research) (DE)
	Group	Germany (govt)
	Product	animal vaccine
	Product 2	business development (state/region)
	Person	Hennemann, Hanjo (VeroVaccines GmbH 201707– Managing Direcotor + Co-Founder before Nexigen GmbH)
	Person 2	Behrens, Sven-Erik (Univ Halle 201805 Professor + VeroVaccines GmbH 201805 Managing Director + Co-Founder)

VEROVACCiNES GmbH is a successful spin-off from the Martin Luther University Halle-Wittenberg, Germany. The co-founders Dr. Hanjo Hennemann and Prof. Dr. Sven-Erik Behrens entered the management of the company as managing directors.

“We are very pleased to get the company started. After achieving a positive votum for our funding application in the federal BMBF GO-Bio-funding program, making VEROVACCiNES eligible for 3.1 m euros funding, it made sense to get the company off the ground. We plan to close the financing round soon and to continue the development of our vaccine programs.” Dr. Hanjo Hennemann said.

Record changed: 2023-06-05

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for VeroVaccines GmbH

[1] VeroVaccines GmbH. (10/14/21). "Press Release: VeroVaccines Closes Series B Financing with Consortium of Investors from Germany and Switzerland". Halle (Saale)....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]